Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Shares Issued (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Shares Issued for 2 consecutive years, with -$138000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 99.92% to -$138000.0 in Q4 2025 year-over-year; TTM through Sep 2025 was -$166.3 million, a N/A change, with the full-year FY2024 number at $51000.0, up 410.0% from a year prior.
  • Shares Issued was -$138000.0 for Q4 2025 at Artiva Biotherapeutics, down from $138000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $166.5 million in Q3 2024 to a low of -$166.5 million in Q4 2024.